New 5th Generation Chemistry from Fluent BioSciences Eliminates Key Limitations of Single Cell Analysis, Achieving 64% Improved Sensitivity
17 Oct 2023
WATERTOWN, Mass., Oct. 17, 2023 /PRNewswire/ -- Fluent BioSciences, a leading life sciences company dedicated to transforming single-cell analysis with innovative, cost-effective, and scalable solutions, announces the launch of the new PIPseq T10 v5.0 Kit. This fifth-generation kit introduces groundbreaking advancements in single-cell analysis, including unique transcript counting through conserved intrinsic molecular features. This new chemistry offers researchers the ability to profile up to 10,000 cells per reaction with a 64% improvement in identified genes per cell compared to previous V4.0PLUS kits.
"At Fluent BioSciences, we're committed to empowering researchers with the tools they need to make groundbreaking discoveries. With this latest innovation, we've not only improved sensitivity but also simplified the entire workflow. We're excited about the impact the PIPseq T10 v5.0 Kit will have on advancing scientific knowledge and accelerating high quality data," states CEO Brian McKernan.
The PIPseq T10 v5.0 Kit offers several additional key advantages, including the new modular design accommodating diverse library preparation methods, thus ensuring a seamless and customizable workflow. The T10 V5.0 kit simplifies the customer experience with user-friendly protocols and streamlines the research process for enhanced efficiency and ease of use. The highly desired T10 V5.0 x 8 reaction configuration grants researchers unmatched flexibility to tailor the kit to their specific research needs.
For more information on the T10 V5.0 kit or to explore the PIPseq technology, please contact our team at [email protected].
Fluent BioSciences is a biotechnology company with a mission to revolutionize the understanding of biology and disease through accessible, affordable, and scalable solutions for every laboratory from research to the clinic. Fluent's breakthrough scRNA-seq technology, PIPseq, allows the power of high quality single-cell biology by providing scalable, cost-effective, and easy to implement scRNA-seq solutions.
SOURCE Fluent BioSciences
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.